JESSICA DAILEY: Open Payments
NPI 1023360864 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,922 in 111 payments from 17 companies in 2025. Trend: 2023 $802 · 2024 $1,644 · 2025 $1,922
Food & beverage: $1,922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $628 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $294 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $171 |
| Madrigal Pharmaceuticals | 11 | $151 |
| Phathom Pharmaceuticals, Inc. | 7 | $94 |
| Aimmune Therapeutics, Inc. | 5 | $92 |
| Janssen Biotech, Inc. | 5 | $90 |
| Celltrion USA Inc. | 5 | $88 |
| Lilly USA, LLC | 4 | $72 |
| GENZYME CORPORATION | 2 | $51 |
Products named: SKYRIZI, ENTYVIO, XIFAXAN, RINVOQ, REZDIFFRA, VOQUEZNA, TREMFYA, VEGZELMA.
Industry payments across OH — which companies pay providers there.
